Page 98 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 3 The Pathology of Neoplasia 77

68. De Campos CB, Damasceno KA, Gamba CO, et al.: Evaluation of 89. Rochat MC, Mann FA, Pace LW, et al.: Identification of surgical
prognostic factors and survival rates in malignant feline mammary biopsy borders by use of india ink, J Am Vet Med Assoc 201:873–
gland neoplasms, J Feline Med Surg 18:1003–1012, 2016. 878, 1992.
VetBooks.ir 69. Kalishman JB, Chappell R, Flood LA, et al.: A matched observa- 90. Kiser PK, Lohr CV, Meritet D, et al.: Histologic processing arti-
facts and inter-pathologist variation in measurement of inked mar-
tional study of survival in cats with enucleation due to diffuse iris
melanoma, Vet Ophthalmol 1:25–29, 1998.
70. Schott CR, Tatiersky LJ, Foster RA, et al.: Histologic grade does gins of canine mast cell tumors, J Vet Diagn Invest 30:377–385,
2018.
not predict outcome in dogs with appendicular osteosarcoma 91. Risselada M, Mathews KG, Griffith E: The effect of specimen prep-
receiving the standard of care, Vet Pathol 55:202–211, 2018. aration on post-excision and post-fixation dimensions, translation,
71. Nemec A, Murphy B, Kass PH, et al.: Histological subtypes of and distortion of canine cadaver skin-muscle-fascia specimens, Vet
oral non-tonsillar squamous cell carcinoma in dogs, J Comp Pathol Surg 45:563–570, 2016.
147:111–120, 2012. 92. Kimyai-Asadi A, Goldberg LH, Jih MH: Accuracy of serial trans-
72. Rasotto R, Berlato D, Goldschmidt MH, et al.: Prognostic sig- verse cross-sections in detecting residual basal cell carcinoma at the
nificance of canine mammary tumor histologic subtypes: an surgical margins of an elliptical excision specimen, J Am Acad Der-
observational cohort study of 229 cases, Vet Pathol 54:571–578, matol 53:469–474, 2005.
2017. 93. Cates JM, Stricker TP: Surgical resection margins in desmoid-type
73. Bonfiglio T, Rogers T: The pathology of cancer. In Rubin P, edi- fibromatosis: a critical reassessment, Am J Pathol 38:1707–1714,
tor: Clinical oncology, ed 6th, American Cancer Society, 1983, pp 2014.
20–29. 94. Dores CB, Milovancev M, Russell DS: Comparison of histologic
74. Holmes MA: Philosophical foundations of evidence-based medi- margin status in low-grade cutaneous and subcutaneous canine
cine for veterinary clinicians, J Am Vet Med Assoc 235:1035–1039, mast cell tumours examined by radial and tangential sections, Vet
2009. Comp Oncol 16:125–130, 2018.
75. Heng YJ, Lester SC, Tse GMK, et al.: The molecular basis of breast 95. Bernstein JA, Storey ES, Bauer RW: Moh’s micrographic surgery
cancer pathological phenotypes, J Pathol 241:375–391, 2017. for the management of a periocular mast cell tumor in a dog, Vet
76. Maiolino P, Cataldi M, Paciello O, et al.: Nucleomorphometric Ophthalmol 16:234–239, 2013.
analysis of canine cutaneous mast cell tumours, J Comp Pathol 96. Bray JP: Soft tissue sarcoma in the dog - part 2: surgical margins,
133:209–211, 2005. controversies and a comparative review, J Small Anim Pract 58:63–
77. Strefezzi RD, Xavier JG, Catao-Dias TL: Morphometry of canine 72, 2017.
cutaneous mast cell tumors, Vet Pathol 40:268–275, 2003. 97. Enneking WF, Spanier SS, Goodman MA: A system for the sur-
78. Russell DS, Townsend KL, Gorman E, et al.: Characterizing micro- gical staging of musculoskeletal sarcoma, Clin Orthop Relat Res
scopical invasion patterns in canine mast cell tumours and soft tis- 106–120, 1980.
sue sarcomas, J Comp Pathol 157:231–240, 2017. 98. Upchurch DA, Malenfant RC, Wignall JR, et al.: Effects of sample
79. Downing S, Chien MB, Kass PH, et al.: Prevalence and importance site and size, skin tension lines, surgeon, and formalin fixation on
of internal tandem duplications in exons 11 and 12 of c-kit in mast shrinkage of skin samples excised from canine cadavers, Am J Vet
cell tumors of dogs, Am J Vet Res 63:1718–1723, 2002. Res 75:1004–1009, 2014.
80. London CA, Hannah AL, Zadovoskaya R, et al.: Phase I dose-esca- 99. Reimer SB, Seguin B, DeCock HE, et al.: Evaluation of the effect
lating study of SU11654, a small molecule receptor tyrosine kinase of routine histologic processing on the size of skin samples obtained
inhibitor, in dogs with spontaneous malignancies, Clin Cancer Res from dogs, Am J Vet Res 66:500–505, 2005.
9:2755–2768, 2003. 100. Kerns MJ, Darst MA, Olsen TG, et al.: Shrinkage of cutaneous
81. Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, et al.: The role of specimens: formalin or other factors involved? J Cutan Pathol
c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell 35:1093–1096, 2008.
tumors, Neoplasia 8:104–111, 2006. 101. Johnson RE, Sigman JD, Funk GF, et al.: Quantification of surgi-
82. London CA, Malpas PB, Wood-Follis SL, et al.: Multi-center, pla- cal margin shrinkage in the oral cavity, Head Neck 19:281–286,
cebo-controlled, double-blind, randomized study of oral toceranib 1997.
phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the 102. Milovancev M, Townsend KL, Bracha S, et al.: Reductions in
treatment of dogs with recurrent (either local or distant) mast cell margin length after excision of grade II mast cell tumors and
tumor following surgical excision, Clin Cancer Res 15:3856–3865, grade I and II soft tissue sarcomas in dogs, Vet Surg 47:36–43,
2009. 2018.
83. Bergin IL, Smedley RC, Esplin DG, et al.: Prognostic evaluation of 103. Murphy S, Sparkes AH, Smith KC, et al.: Relationships between
Ki67 threshold value in canine oral melanoma, Vet Pathol 48:41– the histological grade of cutaneous mast cell tumours in dogs, their
53, 2011. survival and the efficacy of surgical resection, Vet Rec 154:743–746,
84. Moore PF, Rodriguez-Bertos A, Kass PH: Feline gastrointestinal 2004.
lymphoma: mucosal architecture, immunophenotype, and molecu- 104. Simpson AM, Ludwig LL, Newman SJ, et al.: Evaluation of surgi-
lar clonality, Vet Pathol 49:658–668, 2012. cal margins required for complete excision of cutaneous mast cell
85. Langenbach A, McManus PM, Hendrick MJ, et al.: Sensitivity and tumors in dogs, J Am Vet Med Assoc 224:236–240, 2004.
specificity of methods of assessing the regional lymph nodes for 105. Marino DJ, Matthiesen DT, Stefanacci JD, et al.: Evaluation of
evidence of metastasis in dogs and cats with solid tumors, J Am Vet dogs with digit masses: 117 cases (1981-1991), J Am Vet Med Assoc
Med Assoc 218:1424–1428, 2001. 207:726–728, 1995.
86. Krick EL, Billings AP, Shofer FS, et al.: Cytological lymph node 106. Lascelles BD, Parry AT, Stidworthy MF, et al.: Squamous cell
evaluation in dogs with mast cell tumours: association with grade carcinoma of the nasal planum in 17 dogs, Vet Rec 147:473–476,
and survival, Vet Comp Oncol 7:130–138, 2009. 2000.
87. Milovancev M, Russell DS: Surgical margins in the veterinary can- 107. Schwarz PD, Withrow SJ, Curtis CR, et al.: Mandibular resection
cer patient, Vet Comp Oncol 15:1136–1157, 2017. as a treatment for oral-cancer in 81 dogs, J Am Anim Hosp Assoc
88. Scarpa F, Sabattini S, Marconato L, et al.: Use of histologic margin 27:601–610, 1991.
evaluation to predict recurrence of cutaneous malignant tumors in 108. Schwarz PD, Withrow SJ, Curtis CR, et al.: Partial maxillary resec-
dogs and cats after surgical excision, J Am Vet Med Assoc 240:1181– tion as a treatment for oral-cancer in 61 dogs, J Am Anim Hosp
1187, 2012. Assoc 27:617–624, 1991.